Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ashihara

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
British Journal of Haematology|July 11, 2000
Expression of T-cell-associated antigens in B-cell non-Hodgkin's lymphomaT Inaba, C Shimazaki, T Sumikuma, et al.
Cell Death and Differentiation|February 9, 2010
Glyoxalase-I is a novel target against Bcr-Abl+ leukemic cells acquiring stem-like characteristics in a hypoxic environmentM Takeuchi, S Kimura, J Kuroda, et al.
Cell Death and Differentiation|July 12, 2008
The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemiasY Kamitsuji, J Kuroda, S Kimura, et al.
Blood Cancer Journal|July 26, 2012
AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse modelH Yao, E Ashihara, J W Strovel, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
British Journal of Haematology|July 11, 2000
Expression of T-cell-associated antigens in B-cell non-Hodgkin's lymphomaT Inaba, C Shimazaki, T Sumikuma, et al.
Cell Death and Differentiation|February 9, 2010
Glyoxalase-I is a novel target against Bcr-Abl+ leukemic cells acquiring stem-like characteristics in a hypoxic environmentM Takeuchi, S Kimura, J Kuroda, et al.
Cell Death and Differentiation|July 12, 2008
The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemiasY Kamitsuji, J Kuroda, S Kimura, et al.
Blood Cancer Journal|July 26, 2012
AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse modelH Yao, E Ashihara, J W Strovel, et al.
Pageof 9